Lawrence dives in for Parkinson’s

Swim coach Laurie Lawrence.

APN

OLYMPIC and world champion swim coach Laurie Lawrence will add his support to a call for the establishment of a national network of community-based nurses following the publishing of new research into Parkinson's disease.

The findings of the Australian-first Shoalhaven Project reveal the valuable role played by community-based nurses in supporting people living with this devastating, neurodegenerative disease.

This study reveals the crucial role nurses play in significantly improving the quality of life of more than 1-in-350 (64,000) Australians affected by this disease.

One of those 64,000 is Ian Findlay, the former Australian butterfly champion and life-long friend of Lawrence. Findlay was diagnosed with young onset Parkinson's at 40 years of age in 2004.

Lawrence is now urging the Government to fund more community-based Parkinson's nurses in support of Findlay and other sufferers.

"I coached Ian as a young athlete and I know of no one who trained harder than he did. Once he finished his competitive career, I asked Ian to become my assistant coach. We've been friends for 28 years.

"He is a true champion. Ian has tremendous courage and has overcome many obstacles - physical and mental - throughout his distinguished career. Since his diagnosis, he has changed from being an outgoing, bouncy fella to someone who is more introspective and cautious.

"He works incredibly hard to fight the symptoms of Parkinson's with assistance from his hospital-based nurse and his wife, Nicole, who has given up her career as a school teacher to care for him. Both are integral to his physical and mental wellbeing. Having access to a local, community-based nurse would further complement his support network," said Mr Lawrence.

Original post:
Lawrence dives in for Parkinson's

Parkinson’s Disease Stopped in Animal Model

Newswise Millions of people suffer from Parkinson's disease, a disorder of the nervous system that affects movement and worsens over time. As the world's population ages, it's estimated that the number of people with the disease will rise sharply. Yet despite several effective therapies that treat Parkinson's symptoms, nothing slows its progression.

While it's not known what exactly causes the disease, evidence points to one particular culprit: a protein called -synuclein. The protein, which has been found to be common to all patients with Parkinson's, is thought to be a pathway to the disease when it binds together in "clumps," or aggregates, and becomes toxic, killing the brain's neurons.

Now, scientists at UCLA have found a way to prevent these clumps from forming, prevent their toxicity and even break up existing aggregates.

UCLA professor of neurology Jeff Bronstein and UCLA associate professor of neurology Gal Bitan, along with their colleagues, report the development of a novel compound known as a "molecular tweezer," which in a living animal model blocked -synuclein aggregates from forming, stopped the aggregates' toxicity and, further, reversed aggregates in the brain that had already formed. And the tweezers accomplished this without interfering with normal brain function.

The research appears in the current online edition of the journal Neurotherapeutics.

There are currently more than 30 diseases with no cure that are caused by protein aggregation and the resulting toxicity to the brain or other organs, including Parkinson's, Alzheimer's and Type 2 diabetes. It is therefore critical, Bronstein said, to find a way to stop this aggregation process. Over the last two decades, researchers and pharmaceutical companies have attempted to develop drugs that would prevent abnormal protein aggregation, but so far, they have had little or no success.

While these aggregates are a natural target for a drug, finding a therapy that targets only the aggregates is a complicated process, Bronstein said. In Parkinson's, for example, the protein implicated in the disorder, -synuclein, is naturally ubiquitous throughout the brain.

"Its normal function is not well understood, but it may play a role in aiding communication between neurons," Bronstein said. "The trick, then, is to prevent the -synuclein protein aggregates and their toxicity without destroying -synuclein's normal function, along with, of course, other healthy areas of the brain.

Molecular tweezer

Bronstein collaborated with Bitan, who had been working with a particular molecular tweezer he had developed called CLR01. Molecular tweezers are complex molecular compounds that are capable of binding to other proteins. Shaped like the letter "C," these compounds wrap around chains of lysine, a basic amino acid that is a constituent of most proteins.

Continued here:
Parkinson's Disease Stopped in Animal Model

Parkinson’s disease stopped in animal model: Molecular ‘tweezers’ break up toxic aggregations of proteins

ScienceDaily (Mar. 2, 2012) Millions of people suffer from Parkinson's disease, a disorder of the nervous system that affects movement and worsens over time. As the world's population ages, it's estimated that the number of people with the disease will rise sharply. Yet despite several effective therapies that treat Parkinson's symptoms, nothing slows its progression.

While it's not known what exactly causes the disease, evidence points to one particular culprit: a protein called -synuclein. The protein, which has been found to be common to all patients with Parkinson's, is thought to be a pathway to the disease when it binds together in "clumps," or aggregates, and becomes toxic, killing the brain's neurons.

Now, scientists at UCLA have found a way to prevent these clumps from forming, prevent their toxicity and even break up existing aggregates.

UCLA professor of neurology Jeff Bronstein and UCLA associate professor of neurology Gal Bitan, along with their colleagues, report the development of a novel compound known as a "molecular tweezer," which in a living animal model blocked -synuclein aggregates from forming, stopped the aggregates' toxicity and, further, reversed aggregates in the brain that had already formed. And the tweezers accomplished this without interfering with normal brain function.

The research appears in the current online edition of the journal Neurotherapeutics.

There are currently more than 30 diseases with no cure that are caused by protein aggregation and the resulting toxicity to the brain or other organs, including Parkinson's, Alzheimer's and Type 2 diabetes. It is therefore critical, Bronstein said, to find a way to stop this aggregation process. Over the last two decades, researchers and pharmaceutical companies have attempted to develop drugs that would prevent abnormal protein aggregation, but so far, they have had little or no success.

While these aggregates are a natural target for a drug, finding a therapy that targets only the aggregates is a complicated process, Bronstein said. In Parkinson's, for example, the protein implicated in the disorder, -synuclein, is naturally ubiquitous throughout the brain.

"Its normal function is not well understood, but it may play a role in aiding communication between neurons," Bronstein said. "The trick, then, is to prevent the -synuclein protein aggregates and their toxicity without destroying -synuclein's normal function, along with, of course, other healthy areas of the brain.

Molecular tweezer

Bronstein collaborated with Bitan, who had been working with a particular molecular tweezer he had developed called CLR01. Molecular tweezers are complex molecular compounds that are capable of binding to other proteins. Shaped like the letter "C," these compounds wrap around chains of lysine, a basic amino acid that is a constituent of most proteins.

Read more:
Parkinson's disease stopped in animal model: Molecular 'tweezers' break up toxic aggregations of proteins

Parkinson’s Disease (Understanding Disease: Neurology) – Video

26-01-2012 02:51 Get the facts on Parkinson's Disease with this 100%-accurate animated video. Part of Focus Apps' Understanding Disease: Neurology series, the Parkinson's Disease app demonstrates this progressive neurological disorder, which is characterized by tremors, debilitated muscular coordination, weakness, and posture instability. Parkinson's disease is caused by a degeneration of dopamine cells in the movement-control centers of the brain. Explore its causes, classical symptoms, pathophysiology, diagnosis, and treatment. http://www.focusappsstore.net

Here is the original post:
Parkinson's Disease (Understanding Disease: Neurology) - Video

Longmont a select city for creative Parkinson’s disease dance class

LONGMONT -- Shake tambourines. Dance like a gypsy.

Now do it when you are struggling with Parkinson's disease, a progressive neurological disorder that can cause tremors, sluggishness and rigidity.

That's what Stephen Straub asks of his students every Wednesday afternoon during the "Movin' with Parkinson's" class at the Longmont Dance Theatre.

Where: Longmont Dance Theatre, 1422 Nelson Road, Longmont

When: 1 to 2 p.m. Wednesdays

Cost: $5

To register: Call 303-830-1839 or email Info@ParkinsonRockies.org.

More information: Visit ParkinsonRockies.org

Two years ago, Straub traveled to Brooklyn, N.Y., to take a two-day training program called Dance for PD at the Mark Morris Dance Group. The National Parkinson Foundation commissioned renown ballet choreographer Morris to use dance to engage Parkinson's patients.

Only 40 communities worldwide offer the class made available in Longmont last fall, said Kari Buchanan, spokeswoman for Denver-based Parkinson Association of the Rockies.

Read the original:
Longmont a select city for creative Parkinson's disease dance class

Tai chi may help ease Parkinson’s symptoms

Article posted: 2/27/2012 6:00 AM

The ancient Chinese exercise tai chi, shown here at the Oregon Research Institute in Eugene, Ore., improved balance and lowered the risk of falls in a study of people with Parkinson?s disease.

 

Courtesy of the Oregon Research Institute

NEW YORK — The ancient Chinese exercise of tai chi improved balance and lowered the risk of falls in a study of people with Parkinson?s disease.

Symptoms of the brain disorder include tremors and stiff, jerky movements that can affect walking and other activities. Medications and surgery can help, and doctors often recommend exercise or physical therapy.

Tai chi, with its slow, graceful movements, has been shown to improve strength and aid stability in older people, and has been studied for a number of ailments. In the latest study, led by Fuzhong Li of the Oregon Research Institute in Eugene, tai chi was tested in 195 people with mild-to-moderate Parkinson?s.

The participants attended twice-weekly group classes of either tai chi or two other kinds of exercise — stretching and resistance training, which included steps and lunges with ankle weights and a weighted vest.

The tai chi routine was tailored for the Parkinson?s patients, with a focus on ?swing and sway? motions and weight-shifting, said Li, who practices tai chi and teaches instructors.

After six months of classes, the tai chi group did significantly better than the stretching group in tests of balance, control, walking and other measures. Compared with resistance training, the tai chi group did better in balance, control and stride, and about the same in other tests.

Tai chi training was better than stretching in reducing falls, and as effective as resistance training, the researchers reported. The improvements in the tai chi group continued during three months of follow-up.

Li said the study showed tai chi was safe. It?s easy to learn, and there?s no special equipment, he added.

?People are looking for alternative programs, and this could be one of them,? he said.

Estimates vary, but at least 500,000 people in the United States have Parkinson?s.

The findings appeared in the New England Journal of Medicine. The study was paid for by the National Institute of Neurological Disorders and Stroke.

Dr. Chenchen Wang, who is studying tai chi for arthritis and fibromyalgia, said the results of the Parkinson?s research were ?dramatic and impressive.? She heads the Center for Complementary and Integrative Medicine at Tufts Medical Center in Boston.

One of the study?s strengths: Researchers could measure the results directly instead of relying on the patients? own reports, she said. But a placebo effect can?t be totally discounted, she said, since the participants knew which exercise program they were assigned and that could have influenced results.

Visit link:
Tai chi may help ease Parkinson's symptoms

Rare disease leads to Minnesota man’s drastic personality change

Sharon and David DeLeo pose for a picture

Sharon and David DeLeo pose for a picture in September 2011 after Lewy Body disease, a form of dementia often associated with Parkinson’s disease, had taken its toll on him. (Photo courtesy of Sharon DeLeo)

DULUTH, Minn. - Wet and cold, huddled under a blanket in a small Coast Guard rescue boat, the hull of their foundering 53-foot powerboat Hermit Crab barely showing in the Gulf of Mexico, Sharon DeLeo turned to her husband, David.

“I looked up at him and said: ‘Dave, I’ve gone through a lot of things with you, but this takes the cake,’ ” Sharon recalled. “And he laughed.”

It was March 8, 2005, and the Duluth Township couple were in the midst of the most harrowing adventure of an idyllic, fun-loving marriage. They couldn’t have known that just a few months later, they’d begin a much more terrifying struggle.

Lewy Body disease, a form of dementia frequently associated with Parkinson’s disease, would inalterably damage David DeLeo’s mind and drastically change his personality.

“David was the best, the nicest guy,” Sharon DeLeo said during an interview this month in the rustic house they bought in 1987, across North Shore Drive from Lake Superior. He was easygoing, never worried, never bothered by anything.

Lewy Body “turned him into a hallucinogenic, paranoid person,” she said, so violent that one of the caregivers she hired quit in fear.

David’s son Jim DeLeo, a St. Paul-based management consultant, also saw a stark change.

“People wanted to follow him,” Jim said. “He always knew what he wanted to do. Very confident. Very decisive. … After the Lewy Body, when he started having hallucinations, you could see his confidence level wane. There wasn’t that same decisiveness.”

Sharon’s daughter, Jackie Moen of Isanti, Minn., said the change in David was “almost beyond words. To go from the gentle soul who was fun-loving, confident and decisive, to being combative and violent. It was almost like walking in a nightmare.”

It was a bewildering adjustment for his family to make.

“You’re stunned. You’re so stunned by this change in behavior,” said Sharon DeLeo, 72. “David was a totally different person. It was like living with a stranger.”

On Dec. 3, the disease ended his life. He was 75.

‘We had a good life’

David and Sharon DeLeo would have celebrated their 29th wedding anniversary on Saturday. The experiences of the past few years haven’t dimmed Sharon’s memories of most of their time together.

“We had a good life, really,” she said. “We had the kind of marriage where we did whatever we felt like doing. … Our marriage was magical. We were magical together. We didn’t fight. There was nothing to fight about.”

Jim DeLeo, who was a young adult when Dave and Sharon married, remembers their companionship.

“They were absolutely devoted to one another, and everything they did they did together,” he said.

Both David and Sharon grew up on the Iron Range. Their marriage was the second for both, and each had two children, a boy and a girl apiece. He spent 40 years as an executive in the mining industry, including top positions with Reserve Mining and as president of EVTAC. They started a business, Carousel Antiques, in Two Harbors in 1986, and four years later added Shari’s Kitchen, a restaurant. They had a home in Florida as well as in the Northland.

They traveled widely, often on a sailboat. David was an avid, competitive sailor; Sharon, though prone to seasickness, often went with him. “Everybody kept asking me for years, ‘Why do you keep sailing?’ ” she recalled. “Well, I wanted to be with David.”

Jim DeLeo still marvels at that.

“Can you imagine?” he asked. “Getting seasick virtually every time you go out, having to put the patch on or take pills, or whatever. But just muscling your way through it because you wanted to be with him. That’s amazing to me.”

Although David was diagnosed with Parkinson’s in 1990, it didn’t keep the couple from enjoying life. They adjusted their diet and made sure he got plenty of exercise to minimize the effects, Sharon said.

When Parkinson’s forced him to give up sailing in 1995, they switched to a powerboat. The accident occurred about 9 p.m. March 7, 2005, in heavy seas about 35 miles from the Florida Gulf Coast, with only the DeLeos and a cousin of Sharon’s aboard. A waterspout hit, damaging the boat and knocking out its power steering. David steered the boat manually while radioing the Coast Guard. Sharon was lying on a couch, suffering from seasickness. Sharon’s cousin was suffering from a diabetic episode.

After the Coast Guard arrived about 2:30 a.m. the boat took on water, and the three-person crew and two Coast Guardsmen were in the water, swimming against waves toward the Coast Guard boat.

All five people made it to safety, but the DeLeos’ Maltese dog was lost at sea. Sharon DeLeo has two Maltese dogs today, named Sugar and Spice.

‘He wanted a better life’

David still was coping well with the effects of Parkinson’s in 2005, Sharon said, but he wasn’t satisfied.

“His gait was getting more noticeable,” she said. “It did bother him. He was a big, strapping football player, a swimmer in high school and college. … He couldn’t walk like he wanted to walk.”

David sought deep brain stimulation, a surgical procedure in which a device is implanted in the patient’s brain to cut off the abnormal nerve signals that cause Parkinson’s symptoms. The patient must be awake throughout the procedure.

He was turned down by the Mayo Clinic in Rochester, told that a blood-thinning medication he used would make the surgery unsafe. He turned to the Mayo Clinic hospital in Jacksonville, Fla., about a five-hour drive from the couple’s Florida home, and was told that the medication could be suspended for a few days.

“He wanted a better life,” Sharon said. “Poor darling. His life was over with that surgery.”

The procedure was scheduled for Aug. 31, 2005. Two days earlier, David was given a neuropsychological evaluation, but they weren’t told about the results, Sharon said. Instead, the surgeon told them David was a good candidate for the surgery. She didn’t learn until five years later, when she requested medical records from the clinic, that the evaluation found David had symptoms of Lewy Body disease. “I wouldn’t have known what Lewy Body was,” she said. “Someone would have had to explain it to me.”

But David already had shown signs of the illness. Sharon’s son, David Jensen, who is in the construction industry in Florida, said he became aware of his stepfather having hallucinations as early as 2003 or 2004.

Because of the clinical signs of Lewy Body, Sharon believes the procedure never should have been allowed. “One of the criteria is you cannot have deep brain stimulation surgery if you’re showing any signs at all of dementia,” she said.

Dr. Wolcott Holt, a neurologist at Essentia Health in Duluth, said signs of dementia normally preclude the procedure.

“Most places do not do deep brain stimulation when there’s cognitive impairment, because it makes it worse,” Holt said.

The Mayo Clinic hospital in Jacksonville didn’t respond directly to News Tribune questions about Sharon DeLeo’s complaint but said its care was appropriate.

“We extend sincere and deep sympathy to the family for their loss,” spokesman Kevin Punsky said. “Mayo Clinic aspires to provide the best care to every patient every day. We believe the care provided in this case by Mayo Clinic physicians and allied health staff was appropriate. Our respect for patient privacy prevents us from offering any additional information.”

David experienced temporary improvement in his gait, Sharon said. But his loss of short-term memory was immediate and devastating. “He could no longer use the remote control on the television set. He couldn’t use a cell phone, and he certainly couldn’t use a computer,” she said. “And because he was so smart, he could not acquiesce to all this. He just didn’t want to believe it wasn’t somebody else’s fault.”

One night around midnight, she heard him calling DirecTV, claiming there was something wrong with satellite service. Another time, when a light bulb needed to be replaced, he tore out the entire light fixture. “And then, of course, David got so defensive. He knew something was wrong, but he would not admit to it. Oh, life was a nightmare.”

‘She was afraid of David’

David and Sharon moved back to the Northland from Florida for the last time in May 2010, accompanied by Jackie Moen and David Jensen. Moen said her stepfather deteriorated dramatically during the three-day journey, apparently because of highway traffic.

“Movement is very hard on a person with Lewy Body,” she said. “To see that much movement coming at you is terrifying. David was literally shrinking in his seat.”

But the family still didn’t know the cause until later that month, when David was officially diagnosed with Lewy Body at the Struthers Parkinson’s Center in Golden Valley, Minn. By then, hallucinations were occurring frequently.

Jim DeLeo said he witnessed some of those episodes.

“He would say something to me like, ‘What are all those people doing in your car?’ ” Jim recalled. “And I would say, ‘Dad, that’s the Parkinson’s. There’s nobody there.’ And he would kind of grin and accept it. If it came from me, he would accept it.”

But he wouldn’t accept, or trust, the nursing aides Sharon hired to help with his care.

“He was so violent with them,” she said. “He was paranoid. He thought they were stealing from us. He’d grab them and shake them and tell me to reach into their pockets. … He said, ‘You’re stupid! They’re robbing us blind!’ ”

David was still an athletic, powerful man, and he intimidated some of the aides.

After one incident, a caregiver quit, Sharon said. “She was afraid of David when he’d grab her arm and not let go. He was very strong. You couldn’t break his grip.”

And when Sharon tried to correct David in the midst of his hallucinations, she became the enemy.

“There were two Sharons in his life,” she said. “The bad Sharon that my family was afraid he was going to harm. And the other Sharon that he still loved.”

David was never violent toward her, Sharon said. But one night in July 2010 she called 911 after he started talking about double suicide. “That creeps you out at 3 in the morning,” she said. “I thought: Well, what if he covers my face with a pillow?”

It came to a head the next month, when David threw a heavy object at a male caregiver. The other man caught the object, preventing it from flying through a bedroom window, but badly cut his hand in the process. Sharon decided she couldn’t care for her husband at home any longer.

‘It’s beautiful’

But the eight months David spent in assisted-living facilities and hospitals were equally nightmarish, Sharon said. She believes most of the facilities relied far too heavily on medications to regulate his behavior, a process she describes as “snowing” the patient. There still were episodes of violence. He fell while fighting with a caregiver, breaking his hip. David would never walk again.

In January 2011, he nearly died because of a twisted colon.

Sharon wanted to bring David home, but their house wouldn’t readily accommodate a wheelchair. Jensen converted a three-car garage into an assisted-living annex. It wasn’t quite ready when she brought him home on April 1, 2011, but soon the couple moved in and shared the last months of his life together there. A small dining table in the apartment is next to a window that looks out over Lake Superior, where David had spent so much time sailing.

“It’s beautiful,” he said, when he first saw it.

David’s intelligence never diminished, Sharon said, but it became difficult for him to verbalize what he wanted to say. An answer would come 10 minutes after the question, or it would be addressed the next day.

But David remembered family and friends to the end.

“The one thing that never escaped him, even to the day he died, was that ability to remember people and their names and faces,” Jim DeLeo said.

It was the right ending, Sharon said.

“He was home. I was with him. He knew he was home. His family was with him all the time.”

The grieving process is terrible, she said. She’s planning to put the house up for sale this summer. At night, she looks at pictures of David that she keeps on a coffee table. The memories remain.

“David was fun to be married to. He was so easygoing, and life was an adventure with David,” Sharon said. “He was the love of my life.”

Tags: news, health, duluth, updates

See the article here:
Rare disease leads to Minnesota man's drastic personality change

Tai chi may help Parkinson’s patients, study concludes

LOS ANGELES — A six-month program of tai chi exercises helped people with various stages of Parkinson's disease improve stability, their ability to walk and reduced the frequency of falls.

A study released this month in the New England Journal of Medicine compared a six-month tailored tai chi program to resistance training and stretching to see which was most effective at improving functional movement, walking and balance for Parkinson's patients.

Researchers randomly assigned 195 men and women ages 40 to 85 who were in stages one to four of Parkinson's disease (on a scale of one to five). Parkinson's is a neurological disorder caused by a loss of neurons that produce dopamine, a chemical involved with muscle function and movement coordination. It can result in tremors, stiffness, poor coordination and more difficulty doing daily activities. It also can lead to a higher risk of falls, which can cause serious injuries.

Tai chi, a discipline that incorporates slow, deliberate movements, plus breathing, has health benefits that include reducing stress and improving balance and posture.

The study participants were randomly assigned to hourlong, twice-weekly sessions of tai chi, resistance training or stretching, for six months. Researchers assessed their status at the beginning of the study, at three and six months, and three months after the study ended.

The tai chi participants did better than the stretching group on a few measures: leaning without losing balance, having better directional control of their body and walking skills. They outperformed the resistance-training group on balance and stride length. Those in the tai chi group also reduced their frequency of falls more than the stretching group, and they were on a par with the resistance group.

Three months after the study ended, those in the tai chi group were able to maintain the benefits they had gained.

"Since many training features in the program are functionally oriented," Oregon Research Institute scientist Fuzhong Li said, "the improvements in the balance and gait measures that we demonstrated highlight the potential of Tai Chi-based movements in rehabilitating patients with these types of problems and, consequently, easing cardinal symptoms of Parkinson's disease and improving mobility, flexibility, balance and range of motion." Li was the lead author of the study.

He added that tai chi has several advantages: "It is a low-cost activity that does not require equipment, it can be done anywhere, at any time, and the movements can be easily learned. It can also be incorporated into a rehabilitation setting as part of existing treatment. Similarly, because of its simplicity, certain aspects of this Tai Chi program can also be prescribed to patients as a self-care/home activity."

Read more here:
Tai chi may help Parkinson's patients, study concludes

Parkinson’s disease patients get free lifetime access to 23andMe personal genome service.

Share  Email  Print

23andMe are offering free lifetime access to their personal genome service to people who have been diagnosed with Parkinson’s disease for their participation in their Parkinson’s disease research initiative.

Below is a promotional video for the project that highlights Muhammad Ali’s struggle with Parkinson’s disease and his participation in 23andMe’s research program. If you or someone you know has Parkinson’s disease, watch the video, check out the website, and explore your options for participation.

About the Author: Michelle Clement has a B.Sc. in zoology and a M.Sc. in organismal biology, both from The Ohio State University. Her thesis research was on the ecophysiology of epidermal lipids and water homeostasis in house sparrows. She now works as a technical editor for The American Chemical Society. Like this blog on Facebook. Follow on Twitter @physilology.

The views expressed are those of the author and are not necessarily those of Scientific American.

Read the original:
Parkinson's disease patients get free lifetime access to 23andMe personal genome service.

Boxing: Freddie Roach on HBO TV Show, Parkinson’s Disease, Being Famous – Video

18-01-2012 16:46 Famed boxing coach and trainer to Manny Pacquiao, Amir Khan and others - the inimitable Freddie Roach - talks to SB Nation (www.sbnation.com) in this interview about his new HBO miniseries 'On Freddie Roach'. Roach talks about dealing with his Parkinson's, becoming famous, life at Wild Card Gym, how his relationship with his father pushed him into boxing and much more. For more http://www.twitter.com thelukethomas.tumblr.com

Read more from the original source:
Boxing: Freddie Roach on HBO TV Show, Parkinson's Disease, Being Famous - Video

Parkinson’s disease patients can become more creative when they take dopamine

Public release date: 23-Feb-2012
[ | E-mail | Share ]

Contact: Annette Whibley
annette.wizard@gmail.com
Wiley-Blackwell

Some Parkinson's Disease patients can suddenly become creative when they take dopamine therapy, producing pictures, sculptures, novels and poetry. But their new-found interests can become so overwhelming that they ignore other aspects of their everyday life, such as daily chores and social activities, according to research published in the March issue of the European Journal of Neurology.

Italian researchers studied 36 patients with Parkinson's Disease - 18 with increased artistic production and 18 without - and compared them with 36 healthy controls without Parkinson's. None of the patients had engaged in artistic hobbies before they took dopamine.

"Patients were included in the artistic group if they started working on creative projects for two or more hours a day after starting taking dopamine" explains lead author Dr Margherita Canesi, a neurological specialist at the Centro Parkinson e Disordini del Movimento in Milan.

"Our findings suggest that the patients' newly acquired artistic skills were probably there all along, but did not start to emerge until they took the dopamine therapy. They did not appear to be connected with abnormal repetitive behaviours, such as impulse control disorders or punding - stereotyped behavior characterised by an intense fascination with a complex, excessive, non-goal oriented, repetitive activity.

"Other researchers have noted that altered creative drive has been observed in patients who have neurodegenerative diseases or have had a stroke. However the anatomical and physiological understanding of creativity is difficult to establish and quantify."

Dopamine is a neurotransmitter that helps control the brain's reward and pleasure centres. It helps to regulate movement and emotional responses and enables people to see rewards and work towards them. Parkinson's Disease is caused by dopamine deficiency and using medication to increase dopamine levels in the brain is one of the most popular kinds of therapy.

Key findings of the study included:

The artwork presented by the patients was mainly drawings/paintings (83%), poetry/novels (50%) and sculpture (28%). In 78% of cases, the patients showed more than one skill, normally writing plus painting or drawing. Some of the patients produced art that was sold and books that were published, but, at the other end of the scale, some of the creative work was of a very poor quality. By using the Torrence Test of Creative Thinking to compare the three groups, the researchers showed that the artistic Parkinson's Disease patients had similar overall and individual scores to the healthy controls. However the non-artistic patients had significantly lower overall scores than the healthy controls and significantly lower scores than the artistic patients when it came to the elaboration sub-score. There was no correlation between the Torrence Test of Creative Thinking scores and the scores obtained using the Barratt Impulsivity Scale, one of the oldest and most widely used measures of impulsive personality traits. The researchers also used the Minnesota Impulsive Disorders Interview. This showed that one creative patient was positive for compulsive sexual behaviour, one creative patient for compulsive buying and two creative and three non-creative patients for pathological gambling. However, there was little difference in the Torrence scores for patients who tested positive or negative on the Minnesota scale. None of the patients or healthy controls displayed the stereotyped behaviour measured by the Punding Rating Scale.

"In conclusion, we found that newly acquired creative drive in patients with Parkinson's Disease, after the introduction of dopaminergic therapy, is not related to impulsivity or impulse control disorders as measured by the Barratt Impulsivity Scale or the Minnesota Impulsive Disorders Interview" says Dr Canesi.

"We believe that their desire to be creative could represent emerging innate skills, possibly linked to repetitive and reward-seeking behaviours. Further studies are needed to support our preliminary observations."

###

Notes to editors

Artistic productivity and creative thinking in Parkinson's disease. Canesi et al. European Journal of Neurology. 19, pp468-472. (March 2012) doi:10.1111/j.1468-1331.2011.03546.x The European Journal of Neurology covers all areas of clinical and basic research in neurology, including pre-clinical research of immediate translational value for new potential treatments. Emphasis is placed on major diseases or large clinical and socio-economic importance (dementia, stroke, epilepsy, headache, multiple sclerosis, movement disorders, and infectious diseases). The journal provides a forum for European activity in clinical neuroscience and medical practice and helps strengthen the links between research workers and clinicians in Europe and other parts of the world. The journal also publishes the official EFNS taskforce papers. http://wileyonlinelibrary.com/journal/ENE Wiley-Blackwell is the international scientific, technical, medical, and scholarly publishing business of John Wiley & Sons, with strengths in every major academic and professional field and partnerships with many of the world's leading societies. Wiley-Blackwell publishes nearly 1,500 peer-reviewed journals and 1,500+ new books annually in print and online, as well as databases, major reference works and laboratory protocols. For more information, please visit http://www.wileyblackwell.com or our online platform, Wiley Online Library (wileyonlinelibrary.com), one of the world's most extensive multidisciplinary collections of online resources, covering life, health, social and physical sciences, and humanities. [ | E-mail | Share ]

 

AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.

Read more from the original source:
Parkinson's disease patients can become more creative when they take dopamine

Picturing Parkinson’s

It's a staggering number. More than 1 million Americans are living with Parkinson's disease.

Right now, doctors diagnose it by conducting a physical exam that's often unreliable.

But, that's about to change.

William Hill used to be a professional welterweight fighter. Today, he's fighting a different yet powerful opponent, Parkinson's disease.

Debora Bergstrom is also battling the condition that causes tremors, balance problems and speech issues. The mom of three was diagnosed four years ago by a neurologist. "She told me to stand up, walk," Bergstrom said. "She rotated my arms and hands, and she said, 'Yes, you have Parkinson's.'"

But, many people wait years before getting that diagnosis. Doctors physically examine patients for the tell-tale symptoms to formulate their conclusion. However, their observations aren't always accurate. 40 percent of Parkinson's patients are undiagnosed, and at least 10 percent who are diagnosed don't really have it.

Dr. Louise Thomson says a new imaging test called DAT-scan is giving doctors a glimpse inside the Parkinson's brain. First, doctors inject patients with a tracer. Then, they scan the brain for dopamine, a chemical that Parkinson's patients lack.

Thomson says the test can tell doctors if the patient has Parkinson's or just a tremor disorder, which is treated differently. "This is a game changer," she said. "It's going to lead to earlier diagnosis and clearer diagnosis for patients with tremor."

An earlier diagnosis means patients can start treatments sooner, potentially slowing symptom development of this devastating disease.

For William and Debora, every symptom-free day matters. Now, doctors are one step closer to figuring that out.

DAT-scan is the first FDA approved diagnostic imaging test for the assessment of movement disorders such as Parkinson's.

But, there is some debate about its effectiveness.

Some doctors say a negative test doesn't provide enough evidence to rule out Parkinson's completely, and they believe the cost of the scan is much more expensive than a consultation and follow-ups with a movement disorders expert.

Read the original here:
Picturing Parkinson's

Medical Update: Parkinson’s Disease Research – Video

09-11-2011 17:09 David Eidelberg, MD, Director of the Leonard and Susan Feinstein Center for Neurosciences at the Feinstein Institute for Medical Research, discusses new, innovative and non-invasive methods to capture better images of a patients' brain circuitry, eventually leading to earlier and better diagnoses, and the development of effective treatments for Parkinson's and other diseases. Topics include: The Feinstein Institute's endowment as one of the select Morris K. Udall Centers of Excellence in Parkinson's Disease Research, the affiliation agreement between the Feinstein Institute and the Thomas Hartman Foundation for Parkinson's Research to better understand Parkinson's, comparisons of MRI, PetScan and other testing methods, the ability to measure side effects from levodopa, and the ability to scan the brain throughout the course of the disease to identify damaged brain circuits at the earliest stage.

Excerpt from:
Medical Update: Parkinson's Disease Research - Video

LSVT® LOUD Treatment Benefits Parkinson’s Disease Patient — Hendricks Regional Health – Video

31-10-2011 14:20 Nearly 90 percent of patients with Parkinson's Disease (PD) have speech problems that start early in the disease process and progressively worsen. These speech problems can make it difficult for patients to be heard or understood by others, affecting their quality of life. Hendricks Regional Health offers LSVT®LOUD, an innovative treatment protocol that has been proven to improve voice and speech in individuals with PD. The program, offered by our speech therapy team, is recommended for virtually any patient with PD. Patient Ed Burns recently had great success improving his communication skills throughout the course of treatment. Burns works as a call-center representative, so his voice is his livelihood. Hear how this program has made a great difference in his life.

Originally posted here:
LSVT® LOUD Treatment Benefits Parkinson's Disease Patient -- Hendricks Regional Health - Video

New Blood Test for Parkinson’s Studied

Test Has High Degree of Accuracy; Parkinson's Experts Cautiously Optimistic

By Kathleen Doheny
WebMD Health News

Reviewed by Louise Chang, MD

Feb. 22, 2012 -- An experimental blood test for Parkinson's disease is more than 90% accurate in diagnosing the progressive disorder that affects movement and balance, according to its developers.

The test requires a single drop of blood, says Robert Nagele, PhD, a professor of medicine at the University of Medicine and Dentistry of New Jersey School of Osteopathic Medicine.

It looks for specific proteins that are produced by the body in response to Parkinson's disease, he tells WebMD.

Nagele is also the founder of Durin Technologies, the test developer. Another co-researcher is a paid consultant for the company.

No blood test is yet commercially available for Parkinson's, which affects 5 million people worldwide. The study is published in PLoS One.

The news was met with cautious optimism by two experts.

About Parkinson's

In Parkinson's, the nerve cells or neurons in a brain region responsible for muscle movement and coordination deteriorate over time. Normally these cells produce a chemical called dopamine. Dopamine helps regulate such bodily functions as movement.

"Parkinson's affects a specific part of the brain known as the substantia nigra," Nagele says. At least a third of the neurons in this area have already died before symptoms appear, he says.

Symptoms include shaking, tremor, slowness of movement, stiffness in the arms, legs, and trunk, and balance problems.

Doctors diagnose it by taking a medical history and doing a neurological exam.

A blood test could help doctors diagnose and treat the disease earlier. Many teams are working on such tests.

Blood Test for Parkinson's: Study Details

When brain cells die, Nagele says, they explode ''like a water balloon breaking."

The contents of those dying cells spill partially back into the blood. "Their debris is released and your body will sense it and develop autoantibodies to clear that debris," he says.

The new test looks for these autoantibodies in the blood specific to the disease. The researchers narrowed down a list of more than 100 of these autoantibodies to 10 that looked most promising. When these antibodies rise to a certain level, it signals disease, Nagele says.

To evaluate the Parkinson's test, Nagele's team looked at more than 150 blood samples, including:

Overall, the test identified 93% of those who had Parkinson's. It identified correctly 100% of those who did not have it. Both results are considered important.

It could tell the difference between blood samples from patients with Parkinson's, those with the other disorders, and those who were healthy.

Nagele estimates the test, when and if available, would cost about $200.

The new research is a ''proof of principle'' study, he says, and much more research is needed.

Blood Test for Parkinson's: Second Opinion

"It is very exciting to see that many groups around the world have been attempting to develop blood tests for Parkinson's disease," Michael Okun, MD, medical director of the National Parkinson Foundation, tells WebMD. He reviewed the results.

Although Okun calls the new study interesting, he says that ''it only included 29 patients."

However, he remains hopeful that the research will lead to a usable blood test.

"It sounds feasible and probably worth pursuing," says M. Flint Beal, MD, the Anne Parrish Titzell professor of neurology and neuroscience at the Weill Medical College of Cornell University. He also reviewed the findings. He is also developing an early blood test for Parkinson's disease that uses a different approach.

"This is something that should be validated," he says of the new test. "What frequently happens is, the test looks very good initially. When you expand it to a larger population, the accuracy falls off." Further study is needed, he says.

SOURCES: Robert Nagele, PhD, professor of medicine, University of Medicine and Dentistry of New Jersey School of Osteopathic Medicine; founder, Duran Technologies, Inc.PLoS ONE, published online Feb. 22, 2012.Michael Okun, MD, medical director, National Parkinson Foundation.M. Flint Beal, MD, Anne Parrish Titzell professor of neurology and neuroscience, Weill Medical College of Cornell University, Ithaca, N.Y.

©2012 WebMD, LLC. All Rights Reserved.

Go here to see the original:
New Blood Test for Parkinson's Studied

Zumba for Parkinson’s Disease patients – Video

22-12-2011 14:04 In the spring and fall of 2011, BIDMC brought a modified form of the fitness craze ZUMBA to Parkinson's patients and their family members. Co-developer of the Zumba Gold Program, Josie Gardiner, inspired participants to step and sway to a driving Latin beat. The results were, well, moving! The Parkinson's Disease and Movement Disorders Center will be running a winter Zumba Gold class beginning in January 2012. Visit bidmc.org/pdcenter to learn more.

Read the original here:
Zumba for Parkinson's Disease patients - Video